Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.

Lorena P Suarez-Kelly | Kala M Levine | Thomas E Olencki | Sara E Martin Del Campo | Elizabeth A Streacker | Taylor R Brooks | Volodymyr I Karpa | Joseph Markowitz | Anissa K Bingman | Susan M Geyer | Kari L Kendra | William E Carson
Cancer immunology, immunotherapy : CII | 2019

No abstract available

Pubmed ID: 30725205

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: UM1 CA186712
  • Agency: NCI NIH HHS, United States
    Id: P30 CA016058

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BD Biosciences (tool)

RRID:SCR_013311

An Antibody supplier

View all literature mentions